Dextromethorphan is a weak non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist resulting in glutamate inhibition and protected from first-pass metabolism by its co-drug, quinidine, which was shown to be well tolerated in patients with ALS [184]
If you have too much bad bacteria in the gut, it may lead to IBS, Crohn's disease or Ulcerative colitis
This keeps formulas stable and smooth
Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications
The contraindications are due to health concerns
Torres et al., 2017) (Williamson et al., 2019)